IL-21, IL-15, AND IL-12 POLYPEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF

Title:

IL-21, IL-15, AND IL-12 POLYPEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/059634

Kind Code:

A3

Abstract:

The present application provides for polypeptides comprising an IL-21 polypeptide, IL-12 polypeptide, and/or a IL-15 polypeptide, and/or a IL-15 receptor polypeptide; immune checkpoint polypeptides; compositions comprising the same; and methods of using the same.

More Like This:

WO/2016/008034	A METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP)
WO/2014/114787	APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA
JP4603263	Hyaluronic acid-based biomaterial for anti-angioplastic therapy in the treatment of tumors

Inventors:

NIAZI KAYVAN (US)
RABIZADEH SHAHROOZ (US)

Application Number:

PCT/US2023/074071

Publication Date:

May 16, 2024

Filing Date:

September 13, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SAGITTARIUS BIO INC (US)

International Classes:

A61K38/17; A61K38/20; C07K14/54; C07K14/715; A61K48/00; A61P31/00; A61P35/00

Domestic Patent References:

WO2022171853A1	2022-08-18
WO2022165260A1	2022-08-04

Attorney, Agent or Firm:

TISCHNER, Tate, L. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: COMPILING OF TASKS FOR STREAMING OPERATIONS AT NEURAL PROCESSOR

Next Patent: UNIVERSAL T CELL-BASED, CMV-VECTORED VACCINE FOR INFLUENZA